Clinical Trials Browser

Phase 2 × NIH × edotecarin × Clear all

NCT00070031 2013-12-19

Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy

Phase 2 Completed

Breast Neoplasms